Skip to main content

Yesterday, March 8, 2016, 87 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $567.44 to $9,409,592.36.

Highlighted Stocks Traded by Insiders:

Boston Scientific (BSX) - FREE Research Report

Pierce David A, who is SVP and President, Endoscopy at Boston Scientific, sold 51,763 shares at $17.27 on March 8, 2016. Following this transaction, the SVP and President, Endoscopy owned 25,600 shares meaning that the stake was reduced by 66.91% with the 51,763-share transaction.

The shares most recently traded at $17.24, down $0.03, or 0.2% since the insider transaction. Historical insider transactions for Boston Scientific go as follows:

  • 4-Week # shares bought: 30,000
  • 4-Week # shares sold: 190,614
  • 12-Week # shares bought: 30,000
  • 12-Week # shares sold: 267,337
  • 24-Week # shares bought: 30,000
  • 24-Week # shares sold: 466,116

The average volume for Boston Scientific has been 10.0 million shares per day over the past 30 days. Boston Scientific has a market cap of $23.4 billion and is part of the health care sector and health services industry. Shares are down 5.91% year-to-date as of the close of trading on Tuesday.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: Cardiovascular, Rhythm Management, and MedSurg. Currently, there are 14 analysts who rate Boston Scientific a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BSX - FREE

TheStreet Quant Ratings

rates Boston Scientific as a

Scroll to Continue

TheStreet Recommends

hold

. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, weak operating cash flow and generally higher debt management risk. Get the full

Boston Scientific Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Peapack Gladstone Financial (PGC) - FREE Research Report

Daingerfield Richard, who is Director at Peapack Gladstone Financial, bought 1,807 shares at $22.13 on March 8, 2016. Following this transaction, the Director owned 3,954 shares meaning that the stake was boosted by 84.16% with the 1,807-share transaction.

The shares most recently traded at $16.98, down $5.15, or 30.35% since the insider transaction. Historical insider transactions for Peapack Gladstone Financial go as follows:

  • 4-Week # shares bought: 2,718
  • 12-Week # shares bought: 19,218
  • 12-Week # shares sold: 6,000
  • 24-Week # shares bought: 19,218
  • 24-Week # shares sold: 6,000

The average volume for Peapack Gladstone Financial has been 74,600 shares per day over the past 30 days. Peapack Gladstone Financial has a market cap of $270.3 million and is part of the financial sector and banking industry. Shares are down 17.8% year-to-date as of the close of trading on Tuesday.

Peapack-Gladstone Financial Corporation operates as the bank holding company for Peapack-Gladstone Bank that provides private banking and wealth management services primarily to businesses, non-profits, and consumers in New Jersey. The stock currently has a dividend yield of 1.17%. The company has a P/E ratio of 13.3.

Exclusive Offer: Get the latest Stock Analysis on PGC - FREE

TheStreet Quant Ratings

rates Peapack Gladstone Financial as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, expanding profit margins, reasonable valuation levels and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Peapack Gladstone Financial Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Banner (BANR) - FREE Research Report

Rust Steven W, who is Executive VP Banner Bank at Banner, sold 304 shares at $42.02 on March 8, 2016. Following this transaction, the Executive VP Banner Bank owned 8,510 shares meaning that the stake was reduced by 3.44% with the 304-share transaction.

The shares most recently traded at $40.99, down $1.03, or 2.51% since the insider transaction. Historical insider transactions for Banner go as follows:

  • 4-Week # shares bought: 100
  • 4-Week # shares sold: 200
  • 12-Week # shares bought: 100
  • 12-Week # shares sold: 200
  • 24-Week # shares bought: 100
  • 24-Week # shares sold: 1,337

The average volume for Banner has been 155,800 shares per day over the past 30 days. Banner has a market cap of $1.5 billion and is part of the financial sector and banking industry. Shares are down 9.4% year-to-date as of the close of trading on Tuesday.

Banner Corporation operates as the bank holding company for Banner Bank and Islanders Bank that provide commercial banking and financial products and services to individuals, businesses, and public sector entities primarily in the United States. The stock currently has a dividend yield of 1.7%. The company has a P/E ratio of 22.5. Currently, there are 4 analysts who rate Banner a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on BANR - FREE

TheStreet Quant Ratings

rates Banner as a

hold

. The company's strengths can be seen in multiple areas, such as its robust revenue growth and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including a generally disappointing performance in the stock itself, deteriorating net income and disappointing return on equity. Get the full

Banner Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.